Global Medical Foods Market 2023-2029

March 2023 | 65 pages | ID: G2636767808DEN
Gen Consulting Company

Abstracts

The global medical foods market is likely to register a CAGR of over 5.3% with an incremental growth of USD 7.8 billion during the forecast period 2023-2029.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global medical foods market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, route of administration, product, distribution channel, and region. The global market for medical foods can be segmented by product: non-prescription medical foods, prescription medical foods. The non-prescription medical foods segment held the largest revenue share in 2022. Medical foods market is further segmented by application: ADHD (attention-deficit/hyperactivity disorder), Alzheimer’s disease, chemotherapy induced diarrhea, chronic kidney disease (CKD), depression, diabetic neuropathy, infectious diseases, minimal hepatic encephalopathy (MHE), nutritional deficiency, orphan diseases, others. Among these, the diabetic neuropathy segment was accounted for the highest revenue generator in 2022. Based on route of administration, the medical foods market is segmented into: enteral, oral. The oral segment captured the largest share of the market in 2022. On the basis of product, the medical foods market also can be divided into: powder, pills, others. According to the research, the powder segment had the largest share in the global medical foods market. Medical foods market by distribution channel is categorized into: online retailing, institutional sales, retail sales. The medical foods market by region can be segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

Market Segmentation

By product: non-prescription medical foods, prescription medical foods

By application: ADHD (attention-deficit/hyperactivity disorder), Alzheimer’s disease, chemotherapy induced diarrhea, chronic kidney disease (CKD), depression, diabetic neuropathy, infectious diseases, minimal hepatic encephalopathy (MHE), nutritional deficiency, orphan diseases, others

By route of administration: enteral, oral

By product: powder, pills, others

By distribution channel: online retailing, institutional sales, retail sales

By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The market research report covers the analysis of key stake holders of the global medical foods market. Some of the leading players profiled in the report include Abbott Laboratories, Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC (Reckitt Benckiser Group plc), Medtrition,Inc., Nestle S.A., Primus Pharmaceuticals, Inc., Targeted Medical Pharma, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report

• To analyze and forecast the market size of the global medical foods market.
• To classify and forecast the global medical foods market based on product, application, route of administration, product, distribution channel, region.
• To identify drivers and challenges for the global medical foods market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global medical foods market.
• To identify and analyze the profile of leading players operating in the global medical foods market.

Why Choose This Report

• Gain a reliable outlook of the global medical foods market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints

PART 5. MARKET BREAKDOWN BY PRODUCT

Non-prescription medical foods
Prescription medical foods

PART 6. MARKET BREAKDOWN BY APPLICATION

ADHD (attention-deficit/hyperactivity disorder)
Alzheimer’s disease
Chemotherapy induced diarrhea
Chronic kidney disease (CKD)
Depression
Diabetic neuropathy
Infectious diseases
Minimal hepatic encephalopathy (MHE)
Nutritional deficiency
Orphan diseases
Others

PART 7. MARKET BREAKDOWN BY ROUTE OF ADMINISTRATION

Enteral
Oral

PART 8. MARKET BREAKDOWN BY PRODUCT

Powder
Pills
Others

PART 9. MARKET BREAKDOWN BY DISTRIBUTION CHANNEL

Online retailing
Institutional sales
Retail sales

PART 10. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 11. KEY COMPANIES

Abbott Laboratories
Danone S.A.
Fresenius Kabi AG
Mead Johnson & Company, LLC (Reckitt Benckiser Group plc)
Medtrition,Inc.
Nestle S.A.
Primus Pharmaceuticals, Inc.
Targeted Medical Pharma, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER